Venetoclax as a trigger for autoimmune hemolytic anemia in secondary acute myeloid leukemia: A case report
{{output}}
Venetoclax, a BCL-2 inhibitor used in chronic lymphocytic leukemia and acute myeloid leukemia, has been rarely associated with autoimmune hemolytic anemia, mostly in chronic lymphocytic leukemia. We report the first case of venetoclax-triggered autoimmune hemo... ...
